Evidence map›Paper›PMID 38178140›Full record

ReviewJournal of nanobiotechnology2024

New insights into nanotherapeutics for periodontitis: a triple concerto of antimicrobial activity, immunomodulation and periodontium regeneration.

Jiaxin Li, Yuxiao Wang, Maomao Tang, Chengdong Zhang, Yachen Fei, Meng Li, Mengjie Li, Shuangying Gui, Jian Guo

Open access · goldAbstract readReview
In one paragraph

Review in Journal of nanobiotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
22.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 57 citations in OpenAlex.

  1. Trial
  2. TAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jiaxin Li *Department of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, Anhui, China.
Yuxiao Wang *Department of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, Anhui, China.
Maomao TangDepartment of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, Anhui, China.
Chengdong ZhangDepartment of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, Anhui, China.
Yachen FeiDepartment of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, Anhui, China.
Meng LiDepartment of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, Anhui, China.
Mengjie LiDepartment of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, Anhui, China. limj@ahtcm.edu.cn.
Shuangying GuiDepartment of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, Anhui, China. guishy0520@126.com.
Jian GuoDepartment of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, Anhui, China. guoj0719@126.com.
Anhui University of Traditional Chinese Medicine · CN

Funding

Anhui Province University Leading Talents Team No.6High- level Talent Support Program of Anhui University of Chinese Medicine No. 2022rczd003Key Project of Natural Science Research in Universities of Anhui Province 2023AH050785National Natural Science Foundation of China No. 81873019Postgraduate Education Foundation of College of Pharmacy of Anhui University of Chinese Medicine No. 21pyjj05
6 · The paper itself

Abstract

Periodontitis is a chronic inflammatory disease caused by the local microbiome and the host immune response, resulting in periodontal structure damage and even tooth loss. Scaling and root planning combined with antibiotics are the conventional means of nonsurgical treatment of periodontitis, but they are insufficient to fully heal periodontitis due to intractable bacterial attachment and drug resistance. Novel and effective therapeutic options in clinical drug therapy remain scarce. Nanotherapeutics achieve stable cell targeting, oral retention and smart release by great flexibility in changing the chemical composition or physical characteristics of nanoparticles. Meanwhile, the protectiveness and high surface area to volume ratio of nanoparticles enable high drug loading, ensuring a remarkable therapeutic efficacy. Currently, the combination of advanced nanoparticles and novel therapeutic strategies is the most active research area in periodontitis treatment. In this review, we first introduce the pathogenesis of periodontitis, and then summarize the state-of-the-art nanotherapeutic strategies based on the triple concerto of antibacterial activity, immunomodulation and periodontium regeneration, particularly focusing on the therapeutic mechanism and ingenious design of nanomedicines. Finally, the challenges and prospects of nano therapy for periodontitis are discussed from the perspective of current treatment problems and future development trends.

Indexed as

PeriodontitisAnti-Bacterial AgentsHumansImmunityImmunomodulationPeriodontiumRegenerationAnti-Bacterial AgentsAntimicrobial activityImmunomodulationNanotherapeuticsPeriodontitisPeriodontium regenerationSynergistic therapy

Identifiers

PMID38178140
PMCPMC10768271
OpenAlexW4390588841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.